ONC Q1 2019 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q1 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$78M+139.2% YoY

Gross Profit

-$116M-148.8% margin

Operating Income

-$174M-223.2% margin

Net Income

-$168M-215.4% margin

EPS (Diluted)

$-2.86

QoQ Revenue Growth

+32.7%

Cash Flow

Operating Cash Flow

-$172M

Free Cash Flow

-$223M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$550M

Stockholders' Equity

$1.6B

Cash & Equivalents

$764M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$33M	+139.2%
Gross Profit	-$116M	-$82M	-41.7%
Operating Income	-$174M	-$111M	-56.8%
Net Income	-$168M	-$105M	-60.3%